$19.27
0.31%
NYSE, Oct 07, 04:00 pm EDT.
ISIN
US87911J1034
Symbol
HQH

Tekla Healthcare Investors Stock price

$19.27
-3.29 14.58% 1M
+0.99 5.42% 6M
+0.33 1.74% YTD
+0.70 3.77% 1Y
+3.53 22.39% 3Y
-5.95 23.59% 5Y
-4.11 17.58% 10Y
+2.93 17.95% 20Y
NYSE, Closing price Wed, Oct 07 2026
-0.06 0.31%
ISIN
US87911J1034
Symbol
HQH

Is Tekla Healthcare Investors a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.

Key metrics

Basic
Market capitalization
$1.1b
Enterprise Value
$1.1b
Net debt
$0.0
Cash
-
Shares outstanding
57.0m
Valuation
P/E
4.4
P/S | estimate
202.7 | -
EV/Sales | estimate
202.7 | -
EV/FCF | ex SBC
- | -
P/B
1.0
Dividends
DPS
$2.47
Yield 1Y | 5Y
12.8% | 11.0%
Growth 1Y | 5Y
10.3% | 4.2%
Payout 1Y | 3Y
125.8% | 91.0%
Increased
3 Years
Financials
Revenue | estimate
$5.5m | -
EBITDA
-
EBIT
$-6.0m
Net Income
$252.0m
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
-45.6% | -
EBITDA
-
EBIT
-446.4%
Net Income
2,420.0%
Free Cash Flow
-
Margin
Gross
-102.4%
EBITDA
-
EBIT
-108.5%
Net
4,548.7%
Free Cash Flow | ex SBC
- | -
Financial Health
Equity Ratio
99.7%
Return on Equity
9.1%
ROCE
-0.5%
ROIC
-
Debt/Equity
0.0
More
EPS
$4.4
FCF per Share
-
Short interest
-
Employees
-
Rev per Employee
-

Financial data from Tekla Healthcare Investors

Mar '26
+/-
%
5.54 5.54
46% 46%
100%
- Direct Costs 11 11
4% 4%
202%
-5.67 -5.67
950% 950%
-102%
- Selling and Administrative Expenses 0.24 0.24
45% 45%
4%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -6.01 -6.01
446% 446%
-108%
Net Profit 252 252
2,420% 2,420%
4,549%

In millions USD.

Don't miss a Thing! We will send you all news about Tekla Healthcare Investors directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tekla Healthcare Investors Stock News

Neutral
PRNewsWire
●
5 months ago
PHILADELPHIA, May 11, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on May 29, 2026 to all shareholders of record as of May 21, 2026 (ex-dividend...

Company Profile

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.

Head office United States
Founded 1986
Website www.abrdnhqh.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today